Posted in News on July 12th, 2008 No Comments »
Law school dean Rothenberg to chair Maryland Stem Cell Research …Bizjournals.com, NC - Jul 10, 2008The Maryland Stem Cell Research Commission on Thursday appointed Karen Rothenberg as its new chair. Rothenberg is dean and the Marjorie Cook professor of …Group Files Petition Signatures For Mich. Ballot Initiative To … Medical News Today (press release)Law school dean Rothenberg […]
Posted in News on July 12th, 2008 No Comments »
Stem Cells Hold Promise for Muscular DystrophyWashington Post, United States - Jul 10, 2008As for humans, the potential for the new stem cell treatment is unknown. "Researchers will have to devise effective methods for isolating the required …
Posted in News on July 12th, 2008 No Comments »
Purified stem cells restore muscle in mice with muscular dystrophyEurekAlert (press release), DC - Jul 10, 2008In the new study, the researchers analyzed the stem cell and regenerative properties of those SMPs. When engrafted into muscle of mice lacking dystrophin, …
Posted in Research on July 12th, 2008 No Comments »
The U.S. space agency says it’s selected target launch dates for the remaining eight space shuttle missions for 2009 and 2010.
Posted in Research on July 12th, 2008 No Comments »
One Bullitt County mother has taken her five-year-old daughter to China, hoping to save her life.
Posted in Research on July 12th, 2008 No Comments »
Missouri faces stiff competition for jobs and needs to commit to training the work force and creating a climate attractive to business, Republican gubernatorial candidate Kenny Hulshof said Tuesday.
Posted in Articles on July 12th, 2008 No Comments »
A debate over a hypothesis that cancers are fed by cancerous stem cells could affect the path of research.
Posted in Articles on July 12th, 2008 No Comments »
After years of searching, Shinya Yamanaka found a way to turn adult skin cells into the equivalent of human embryonic stem cells without using an actual embryo.
Posted in Stem Cell on July 12th, 2008 No Comments »
Opexa Therapeutics, Inc. has announced today the Data Safety Monitoring Board (DSMB) has recommended the trial of Tovaxin to continue unmodified. Opexa Therapeutics, Inc. is the company that develops cell therapies for multiple sclerosis. This positive recommendation follows a regularly scheduled meeting of the DSMB in June and is based upon an evaluation of […]